HK1044336A1 - 治療糖尿病及衰老相關性血管性並發症的吡啶衍生物 - Google Patents
治療糖尿病及衰老相關性血管性並發症的吡啶衍生物Info
- Publication number
- HK1044336A1 HK1044336A1 HK02105890.8A HK02105890A HK1044336A1 HK 1044336 A1 HK1044336 A1 HK 1044336A1 HK 02105890 A HK02105890 A HK 02105890A HK 1044336 A1 HK1044336 A1 HK 1044336A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diabetic
- aging
- treatment
- vascular complications
- related vascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN827CA1999 | 1999-10-06 | ||
PCT/IB1999/001687 WO2001025209A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1044336A1 true HK1044336A1 (zh) | 2002-10-18 |
Family
ID=11084921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02105890.8A HK1044336A1 (zh) | 1999-10-06 | 2002-08-12 | 治療糖尿病及衰老相關性血管性並發症的吡啶衍生物 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1220843A1 (zh) |
JP (1) | JP2003511370A (zh) |
CN (1) | CN1329597A (zh) |
AU (1) | AU5994499A (zh) |
BR (1) | BR9915962A (zh) |
CA (1) | CA2351075A1 (zh) |
CZ (1) | CZ20011808A3 (zh) |
HK (1) | HK1044336A1 (zh) |
HU (1) | HUP0301687A2 (zh) |
MX (1) | MXPA02003496A (zh) |
PL (1) | PL348049A1 (zh) |
WO (1) | WO2001025209A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004525904A (ja) * | 2000-12-29 | 2004-08-26 | アルテオン インコーポレイテッド | 線維性疾患又は他の適応症iiicの治療方法 |
CZ303214B6 (cs) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití |
ES2243389T3 (es) * | 2001-03-21 | 2005-12-01 | Torrent Pharmaceuticals Ltd | Compuestos de piridinio utiles para el tratamiento de enfermedades relacionadas con los age. |
CA2439593C (en) | 2001-04-05 | 2010-02-09 | Torrent Pharmaceuticals Ltd. | Heterocyclic compounds for aging-related and diabetic vascular complications |
HUP0104832A2 (en) * | 2001-10-19 | 2003-08-28 | Torrent Pharmaceuticals Ltd | Cosmetic composition and method |
GB0328314D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Bath | Therapeutics |
WO2007132179A2 (en) * | 2006-05-15 | 2007-11-22 | University Of Bath | Therapeutics comprising pyridinium derivatives |
JP2009155315A (ja) * | 2007-12-26 | 2009-07-16 | Fujiyakuhin Co Ltd | 注射剤 |
EP2427432A2 (en) * | 2009-05-07 | 2012-03-14 | Torrent Pharmaceuticals Limited | Novel heterocyclic compounds |
ES2899694T3 (es) * | 2012-10-05 | 2022-03-14 | Sphaera Pharma Pte Ltd | Compuestos novedosos, su síntesis y sus usos |
CA2997364A1 (en) * | 2015-04-08 | 2016-10-13 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH335521A (de) * | 1955-06-02 | 1959-01-15 | Cilag Ag | Verfahren zur Herstellung neuer quaternärer Salze |
US3318787A (en) * | 1964-02-07 | 1967-05-09 | Udylite Corp | Electrodeposition of zinc |
US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
JPS5936247B2 (ja) * | 1977-04-20 | 1984-09-03 | ティーディーケイ株式会社 | 電気的表示装置 |
JPS55138742A (en) * | 1979-04-17 | 1980-10-29 | Fuji Photo Film Co Ltd | Silver halide emulsion developing method |
JPH0253759A (ja) * | 1988-08-18 | 1990-02-22 | Hamari Yakuhin Kogyo Kk | 新規な4級アンモニウム化合物 |
DD275872A1 (de) * | 1988-09-27 | 1990-02-07 | Univ Dresden Tech | Verfahren zur herstellung von 5h-pyrido[1',2':1,2]imidazo[5,4-c]chinolin-6-onen |
WO1996022095A2 (en) * | 1995-01-18 | 1996-07-25 | Alteon Inc. | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
JP2001519813A (ja) * | 1997-04-04 | 2001-10-23 | スミスクライン・ビーチャム・コーポレイション | カルシウム溶解性化合物 |
-
1999
- 1999-10-15 PL PL99348049A patent/PL348049A1/xx not_active Application Discontinuation
- 1999-10-15 MX MXPA02003496A patent/MXPA02003496A/es unknown
- 1999-10-15 WO PCT/IB1999/001687 patent/WO2001025209A1/en not_active Application Discontinuation
- 1999-10-15 HU HU0301687A patent/HUP0301687A2/hu unknown
- 1999-10-15 EP EP99974071A patent/EP1220843A1/en not_active Withdrawn
- 1999-10-15 CN CN99814055A patent/CN1329597A/zh active Pending
- 1999-10-15 JP JP2001528155A patent/JP2003511370A/ja active Pending
- 1999-10-15 BR BR9915962-7A patent/BR9915962A/pt not_active IP Right Cessation
- 1999-10-15 AU AU59944/99A patent/AU5994499A/en not_active Abandoned
- 1999-10-15 CA CA002351075A patent/CA2351075A1/en not_active Abandoned
- 1999-10-15 CZ CZ20011808A patent/CZ20011808A3/cs unknown
-
2002
- 2002-08-12 HK HK02105890.8A patent/HK1044336A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2003511370A (ja) | 2003-03-25 |
MXPA02003496A (es) | 2005-06-20 |
EP1220843A1 (en) | 2002-07-10 |
WO2001025209A1 (en) | 2001-04-12 |
CA2351075A1 (en) | 2001-04-12 |
CZ20011808A3 (cs) | 2001-08-15 |
HUP0301687A2 (hu) | 2003-08-28 |
PL348049A1 (en) | 2002-05-06 |
AU5994499A (en) | 2001-05-10 |
CN1329597A (zh) | 2002-01-02 |
BR9915962A (pt) | 2003-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
NO952573D0 (no) | Blandinger for behandling av diabetiske komplikasjoner | |
HK1048949A1 (en) | Method and composition for the treatment of scars | |
AU2045401A (en) | Blood vessel catheter | |
AU1927399A (en) | Catheter apparatus for treating arterial occlusions | |
HUP0104116A3 (en) | Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof | |
HU9802721D0 (en) | Method and composition for the treatment and prevention of hyperuricemia | |
AU1585101A (en) | Absorbent article with skin treatment means | |
HK1044336A1 (zh) | 治療糖尿病及衰老相關性血管性並發症的吡啶衍生物 | |
AU5240700A (en) | Naphthoquinone derivatives and their use in the treatment and control of tuberculosis | |
HUP0200738A3 (en) | Method of the treatment of incontinence | |
AU8758998A (en) | Catheter advancing single-handed soft passer | |
AU4770800A (en) | Body treatment product | |
AU1792901A (en) | Methods for treating and preventing diabetic complications | |
AU2001244461A1 (en) | Venous line catheter and method of operating the same | |
AU6648200A (en) | Method and composition for preventing or treating adverse physiological effects associated with cardiac disease | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
EP1126856A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE IN DIABETIC COMPLICATIONS | |
IL150202A0 (en) | Method and composition for the treatment of pain | |
AU4612900A (en) | Sod-like composition and blood-pressure controlling agent | |
IL150208A0 (en) | Compound and method for the treatment of pain | |
AU2899099A (en) | Composition for treatment and prevention of coronary artery disease | |
AU2420201A (en) | Compounds and methods for the treatment of pain | |
IL143795A0 (en) | Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections | |
AUPQ299899A0 (en) | Disulphide useful in the treatment of cardiovascular diseases |